BIOCORP: Full-Year 2021 Financial Results and Outlook for 2022

Record revenues up 20% to €10.2 million Cost control with a 3.3% increase in operating expenses Positive annual net income of €0.3 million Mallya's first commercial launches

Related Keywords

Taiwan ,United States ,Paris ,France General ,France ,Spain ,Spanish ,French ,Taiwanese ,Sylvaine Dessard ,Jacques Gardette ,Research Tax Credit ,Novo Nordisk ,Euronext ,Roche Diabetes Care ,While Mallya ,Tax Credit ,Innovation Tax Credit ,Life Cycle Management ,Executive Officer ,Communication Director ,Biocorp ,Bull ,Ear ,021 ,Financial ,Results ,Outlook ,022 ,